medigraphic.com
ISSN 2448-8720 (Print)
Organo Oficial de la Secretaria de Salud de Quintana Roo

2016, Number 34

<< Back Next >>

Salud Quintana Roo 2016; 9 (34)

Clinical profile women with and without human papiloma virus infection in Quintana Roo

Guarneros-Cuellar AR, Reyes-Gabino PT, Jiménez-Baez MV, Sandoval-Jurado L

Language: Spanish
References: 19
Page: 6-11
PDF size: 557.24 Kb.


ABSTRACT

Introduction. Human papillomavirus Infection (HPVI) is the main etiology for cervical cancer when associated with a clinical profile defined by risk factors. The aim of the study was to describe the clinical profile of women with and without HPVI detected by Papanicolaou in a primary care clinic in the state of Quintana Roo.
Materials and method. Analytical descriptive study of 281 women aged 21 to 64 years with Pap test, who was determined in clinical profile and differences with and without HPVI. As statistical test Student test and Chi square according to the type of variables were used, a value of 0.05 was considered significant. RP (prevalence ratio) was determined according to the group.
Results. The average age of women of study was 38.46 ± 2.9 years; 79 patients (28.1%) with HPVI and 202 (71.9%) without HPVI; It was found that patients had 3.9 and 2.32 sexual partners for women with and without HPVI. The frequency of making cytology was 4.42 years [95% CI (1.1-1.9)] and 1.92 years [95% CI 1.0-1.9] for women with and without infection respectively. To HPVI found a PR = 0.66, background of human immunodeficiency virus (HIV) RP = 7.77, sexually transmitted diseases RP = 1.17 and a family history of cervical cancer RP = 1.73.
Conclusions.The clinical profile of women with HPVI in Quintana Roo differs from that reported in international studies in terms of age, education, number of pregnancies and couples. Seven out of 10 women living with HIV are at risk of developing HPVI. Factors such as HIV, STD and family history of cervical cancer increases the risk of transmission HPVI.


REFERENCES

  1. Hernández-Valencia M, Rodríguez-Lundes O, Landero-Montes De Oca, Pichardo-García R, Escamilla-Godinez G. Factores de riesgo asociados a alteraciones histológicas del aparato genital en pacientes de primer nivel de atención. Cir Ciruj 2009; 77: 451-454.

  2. Hernández-Valencia M, Carrillo-Pacheco A, Hernández-Quijano T. El Papanicolaou para detectar cambios celulares por el virus del papiloma humano. Rev Med Inst Mex Seguro Soc. 2013; 51(4):420-423.

  3. De La Fuente-Villarreal D, Guzmán-López S, Barboza-Quintana O, Gonzalez-Ramirez R. Biología del Virus del Papiloma Humano y técnicas de diagnóstico. Medicina Universitaria 2010; 12(49): 231-238.

  4. World Health Organization. Human papillomavirus (HPV) and cervical cancer. Media Center [base de datos en Internet] 2016 [fecha de consulta: 01 agosto 2016]. Disponible en: http://www.who.int/mediacentre/factsheets/ fs380/en/

  5. Centros para el control y prevención de enfermedades. EL VPH y el cáncer [base de datos en Internet] 2016 [fecha de consulta: 01 agosto 2016]. Disponible en: http://www.cdc.gov/spanish/cancer/hpv/statistics/

  6. Centros para el control y prevención de enfermedades. EL VPH y el cáncer, estadísticas [base de datos en Internet]. Disponible en: http://www.cdc.gov/ spanish/cancer/hpv/statistics/cases.htm

  7. Instituto Nacional de Estadística y Geografía. Mujeres y hombres en México 2014 [base de datos en Internet] 2014 [fecha de consulta: 01 agosto 2016]. Disponible en: http://cedoc.inmujeres.gob.mx/documentos_ download/101239.pdf

  8. Medina-Villaseñor E, Oliver-Parra P, Neyra-Ortiz E, Pérez-Castro J, Sánchez- Orozco J, Contreras-González N. Neoplasia intraepitelial cervical, análisis de las características clínico patológicas. GAMO 2014;13(1):12-25.

  9. Salazar-Lucia E, González-Luis J. Influencia del uso de anticonceptivos orales como factores de riesgo para infección por virus del papiloma humano y neoplasia intraepitelial cervical. Ginecol Obstet Mex 2005;73:83-89.

  10. Lizano-Soberón M, Carrillo-García A, Contreras-Paredes A. Infección por virus del Papiloma humano: epidemiologia, historia natural, carcinogénesis. Cancerología 4. (2009): 205-216.

  11. López-Galván J, Villa-Barajas R, Martínez-Madrigal F. Relación entre displasia cérvico uterina y virus del papiloma humano en una unidad de medicina familiar de Michoacan, México. Atención Familiar 2011; 18(2): 38- 40.

  12. Rodríguez-Lundes O, Pichardo-García R, Escamilla-Godínez G, Hernández- Valencia M. Estudio de la patología citológica del cérvix. Perinatol Reprod Hum 2009; 23: 12-17.

  13. López-Olmos J, Gasull J. Infección por tricomonas (e infecciones mixtas) y atipias celulares, en la citología cervicovaginal. Clin Invest Gin Obst. 2011;38(4):120-127.

  14. Johnson-M Anne, Mercer- H Catherine, Beddows Simon, De Silva Natasha, Desai Sarika, Howell-Jones R, Et. Al. Epidemiology of, and behavioural risk factors for sexually transmitted human papillomavirus infection in men and women in Britain. Sex Transm Infect 2012;88:212-217.

  15. Nuñez-Troconis J, Delgado M, González J, Mindiola R, Velásquez J, Conde B, et al. Prevalence and risk factors of human papillomavirus infection in asymptomatic women in a Venezuela urban area. Invest Clin 2009;50(2): 203- 212.

  16. Bennani B, Bennis S, Nejjari C, Ouafik L´H, Melhouf-Abdelilah M, El Rhazi K, et. al. Correlates of HPV: a cross-sectional study with normal citologiy in north-central Morocco. J Infect Dev Ctries 2012; 6(7):543-550.

  17. Confortini M, Carozzi F, Zappa M, Ventura L, Iossa A, Cariaggi P, et. al. Human papillomavirus infection and risk factors in cohort of Tuscan women aged 18-24: results at recruitment. BMC Infectious Diseases 2010; 10:157- 168.

  18. Moscicki AB, Ellenberg JH, Farhat S, Xu J. Persistence of human Risk factors and differences, by phylogeic Type. JID 2004:37-45.

  19. Briseño H. Impacto y prevalencia de los factores de riesgo en cáncer cervicouterino. Archivos Médicos de Actualización en Tracto Genital Inferior 2010: 5-9.




2020     |     www.medigraphic.com